Autoimmune Hepatitis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: AEF6377B4A6EEN
Market Monitor Global

Abstracts

Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body's own immune system attacks the liver and causes it to become inflamed.

This report contains market size and forecasts of Autoimmune Hepatitis Treatment in Global, including the following market information:

Global Autoimmune Hepatitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Autoimmune Hepatitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Table Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autoimmune Hepatitis Treatment include Gilead Sciences, Inc., Acorda Therapeutics, Inc., Allergan & Novartis, Intercept Pharmaceuticals, Inc., Hightidetx, Shire Plc., NGM Biopharmaceuticals, Inc., EA Pharma and BiomX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autoimmune Hepatitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autoimmune Hepatitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Autoimmune Hepatitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Table Product
• Inject Product
• Others

Global Autoimmune Hepatitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Autoimmune Hepatitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Autoimmune Hepatitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Autoimmune Hepatitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autoimmune Hepatitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Autoimmune Hepatitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences, Inc.
• Acorda Therapeutics, Inc.
• Allergan & Novartis
• Intercept Pharmaceuticals, Inc.
• Hightidetx
• Shire Plc.
• NGM Biopharmaceuticals, Inc.
• EA Pharma
• BiomX
• CymaBay Therapeutics
• Conatus Pharmaceuticals, Inc.
• Durect Corporation
• Sirnaomics, Inc.
• Shenzhen HighTide Biopharmaceuticals Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autoimmune Hepatitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autoimmune Hepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTOIMMUNE HEPATITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Autoimmune Hepatitis Treatment Market Size: 2021 VS 2028
2.2 Global Autoimmune Hepatitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autoimmune Hepatitis Treatment Players in Global Market
3.2 Top Global Autoimmune Hepatitis Treatment Companies Ranked by Revenue
3.3 Global Autoimmune Hepatitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Hepatitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Autoimmune Hepatitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Hepatitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Autoimmune Hepatitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Hepatitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Autoimmune Hepatitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Table Product
  4.1.3 Inject Product
  4.1.4 Others
4.2 By Type - Global Autoimmune Hepatitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Autoimmune Hepatitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Autoimmune Hepatitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autoimmune Hepatitis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Autoimmune Hepatitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Autoimmune Hepatitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Autoimmune Hepatitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Autoimmune Hepatitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Autoimmune Hepatitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Autoimmune Hepatitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Autoimmune Hepatitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Autoimmune Hepatitis Treatment Revenue, 2017-2028
  6.3.2 US Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.3.3 Canada Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Autoimmune Hepatitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Autoimmune Hepatitis Treatment Revenue, 2017-2028
  6.4.2 Germany Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.4.3 France Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.4.5 Italy Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.4.6 Russia Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Autoimmune Hepatitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Autoimmune Hepatitis Treatment Revenue, 2017-2028
  6.5.2 China Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.5.3 Japan Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.5.6 India Autoimmune Hepatitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Autoimmune Hepatitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Autoimmune Hepatitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autoimmune Hepatitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.7.3 Israel Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Autoimmune Hepatitis Treatment Market Size, 2017-2028
  6.7.5 UAE Autoimmune Hepatitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead Sciences, Inc.
  7.1.1 Gilead Sciences, Inc. Corporate Summary
  7.1.2 Gilead Sciences, Inc. Business Overview
  7.1.3 Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.1.4 Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Gilead Sciences, Inc. Key News
7.2 Acorda Therapeutics, Inc.
  7.2.1 Acorda Therapeutics, Inc. Corporate Summary
  7.2.2 Acorda Therapeutics, Inc. Business Overview
  7.2.3 Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.2.4 Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Acorda Therapeutics, Inc. Key News
7.3 Allergan & Novartis
  7.3.1 Allergan & Novartis Corporate Summary
  7.3.2 Allergan & Novartis Business Overview
  7.3.3 Allergan & Novartis Autoimmune Hepatitis Treatment Major Product Offerings
  7.3.4 Allergan & Novartis Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Allergan & Novartis Key News
7.4 Intercept Pharmaceuticals, Inc.
  7.4.1 Intercept Pharmaceuticals, Inc. Corporate Summary
  7.4.2 Intercept Pharmaceuticals, Inc. Business Overview
  7.4.3 Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.4.4 Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Intercept Pharmaceuticals, Inc. Key News
7.5 Hightidetx
  7.5.1 Hightidetx Corporate Summary
  7.5.2 Hightidetx Business Overview
  7.5.3 Hightidetx Autoimmune Hepatitis Treatment Major Product Offerings
  7.5.4 Hightidetx Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Hightidetx Key News
7.6 Shire Plc.
  7.6.1 Shire Plc. Corporate Summary
  7.6.2 Shire Plc. Business Overview
  7.6.3 Shire Plc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.6.4 Shire Plc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Shire Plc. Key News
7.7 NGM Biopharmaceuticals, Inc.
  7.7.1 NGM Biopharmaceuticals, Inc. Corporate Summary
  7.7.2 NGM Biopharmaceuticals, Inc. Business Overview
  7.7.3 NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.7.4 NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.7.5 NGM Biopharmaceuticals, Inc. Key News
7.8 EA Pharma
  7.8.1 EA Pharma Corporate Summary
  7.8.2 EA Pharma Business Overview
  7.8.3 EA Pharma Autoimmune Hepatitis Treatment Major Product Offerings
  7.8.4 EA Pharma Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.8.5 EA Pharma Key News
7.9 BiomX
  7.9.1 BiomX Corporate Summary
  7.9.2 BiomX Business Overview
  7.9.3 BiomX Autoimmune Hepatitis Treatment Major Product Offerings
  7.9.4 BiomX Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.9.5 BiomX Key News
7.10 CymaBay Therapeutics
  7.10.1 CymaBay Therapeutics Corporate Summary
  7.10.2 CymaBay Therapeutics Business Overview
  7.10.3 CymaBay Therapeutics Autoimmune Hepatitis Treatment Major Product Offerings
  7.10.4 CymaBay Therapeutics Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.10.5 CymaBay Therapeutics Key News
7.11 Conatus Pharmaceuticals, Inc.
  7.11.1 Conatus Pharmaceuticals, Inc. Corporate Summary
  7.11.2 Conatus Pharmaceuticals, Inc. Business Overview
  7.11.3 Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.11.4 Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.11.5 Conatus Pharmaceuticals, Inc. Key News
7.12 Durect Corporation
  7.12.1 Durect Corporation Corporate Summary
  7.12.2 Durect Corporation Business Overview
  7.12.3 Durect Corporation Autoimmune Hepatitis Treatment Major Product Offerings
  7.12.4 Durect Corporation Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.12.5 Durect Corporation Key News
7.13 Sirnaomics, Inc.
  7.13.1 Sirnaomics, Inc. Corporate Summary
  7.13.2 Sirnaomics, Inc. Business Overview
  7.13.3 Sirnaomics, Inc. Autoimmune Hepatitis Treatment Major Product Offerings
  7.13.4 Sirnaomics, Inc. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.13.5 Sirnaomics, Inc. Key News
7.14 Shenzhen HighTide Biopharmaceuticals Ltd.
  7.14.1 Shenzhen HighTide Biopharmaceuticals Ltd. Corporate Summary
  7.14.2 Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview
  7.14.3 Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Major Product Offerings
  7.14.4 Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Revenue in Global Market (2017-2022)
  7.14.5 Shenzhen HighTide Biopharmaceuticals Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Autoimmune Hepatitis Treatment Market Opportunities & Trends in Global Market
Table 2. Autoimmune Hepatitis Treatment Market Drivers in Global Market
Table 3. Autoimmune Hepatitis Treatment Market Restraints in Global Market
Table 4. Key Players of Autoimmune Hepatitis Treatment in Global Market
Table 5. Top Autoimmune Hepatitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Autoimmune Hepatitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Autoimmune Hepatitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Autoimmune Hepatitis Treatment Product Type
Table 9. List of Global Tier 1 Autoimmune Hepatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Hepatitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Autoimmune Hepatitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Autoimmune Hepatitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Autoimmune Hepatitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Autoimmune Hepatitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Autoimmune Hepatitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Autoimmune Hepatitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Sciences, Inc. Corporate Summary
Table 31. Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Product Offerings
Table 32. Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Acorda Therapeutics, Inc. Corporate Summary
Table 34. Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Product Offerings
Table 35. Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Allergan & Novartis Corporate Summary
Table 37. Allergan & Novartis Autoimmune Hepatitis Treatment Product Offerings
Table 38. Allergan & Novartis Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Intercept Pharmaceuticals, Inc. Corporate Summary
Table 40. Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product Offerings
Table 41. Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Hightidetx Corporate Summary
Table 43. Hightidetx Autoimmune Hepatitis Treatment Product Offerings
Table 44. Hightidetx Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Shire Plc. Corporate Summary
Table 46. Shire Plc. Autoimmune Hepatitis Treatment Product Offerings
Table 47. Shire Plc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. NGM Biopharmaceuticals, Inc. Corporate Summary
Table 49. NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product Offerings
Table 50. NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. EA Pharma Corporate Summary
Table 52. EA Pharma Autoimmune Hepatitis Treatment Product Offerings
Table 53. EA Pharma Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. BiomX Corporate Summary
Table 55. BiomX Autoimmune Hepatitis Treatment Product Offerings
Table 56. BiomX Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. CymaBay Therapeutics Corporate Summary
Table 58. CymaBay Therapeutics Autoimmune Hepatitis Treatment Product Offerings
Table 59. CymaBay Therapeutics Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Conatus Pharmaceuticals, Inc. Corporate Summary
Table 61. Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product Offerings
Table 62. Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Durect Corporation Corporate Summary
Table 64. Durect Corporation Autoimmune Hepatitis Treatment Product Offerings
Table 65. Durect Corporation Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Sirnaomics, Inc. Corporate Summary
Table 67. Sirnaomics, Inc. Autoimmune Hepatitis Treatment Product Offerings
Table 68. Sirnaomics, Inc. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Shenzhen HighTide Biopharmaceuticals Ltd. Corporate Summary
Table 70. Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Product Offerings
Table 71. Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Autoimmune Hepatitis Treatment Segment by Type in 2021
Figure 2. Autoimmune Hepatitis Treatment Segment by Application in 2021
Figure 3. Global Autoimmune Hepatitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autoimmune Hepatitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autoimmune Hepatitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autoimmune Hepatitis Treatment Revenue in 2021
Figure 8. By Type - Global Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Autoimmune Hepatitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Autoimmune Hepatitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Allergan & Novartis Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hightidetx Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Shire Plc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. EA Pharma Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BiomX Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CymaBay Therapeutics Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Durect Corporation Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sirnaomics, Inc. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)